William W Hope (William Hope, W Hope)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 57

Top Venues

Antimicrobial agents and chemotherapy

CPT: pharmacometrics & systems pharmacology

mBio

Clinical microbiology reviews

University of Liverpool

University of Queensland (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Liverpool Jun 01 2012

United Kingdom

Dame Sally Davies Chair of AMR Research :: Molecular and Clinical Pharmacology

Education History

University of Queensland

Australia

PHD

Publications

Nada Reza, Alessandro Gerada, Katharine E Stott, Alex Howard, Michael Sharland, William W Hope
Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing. Clinical microbiology reviews 37 (2) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Katharine E Stott, Jason T Mohabir, Katharine Bowers, Jennifer L Tenor, Dena L Toffaletti, Jennifer Unsworth, Ana Jimenez-Valverde, Ajisa Ahmadu, Melanie Moyo, Ebbie Gondwe, Wezi Chimang'anga, Madalitso Chasweka, David S Lawrence, Joseph N Jarvis, Tom Harrison, William W Hope, David G Lalloo, Henry C Mwandumba, John R Perfect, Christina A Cuomo, null null
Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitis. mBio (2024)
Nada Reza, Alessandro Gerada, Katharine E Stott, Alex Howard, Michael Sharland, William W Hope
Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing. Clinical microbiology reviews 37 (2) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Alessandro Gerada, Nicholas Harper, Alex Howard, Nada Reza, William W Hope
Determination of minimum inhibitory concentrations using machine-learning-assisted agar dilution. Microbiology spectrum 12 (5) (2024)
Nada Reza, Alessandro Gerada, Katharine E Stott, Alex Howard, Michael Sharland, William W Hope
Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing. Clinical microbiology reviews 37 (2) (2024)
Alessandro Gerada, Nicholas Harper, Alex Howard, Nada Reza, William W Hope
Determination of minimum inhibitory concentrations using machine-learning-assisted agar dilution. Microbiology spectrum 12 (5) (2024)
Nicola Farrington, Vineet Dubey, Adam Johnson, Iona Horner, Adam Stevenson, Jennifer Unsworth, Ana Jimenez-Valverde, Julie Schwartz, Shampa Das, William W Hope, Christopher A Darlow
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa . mBio 15 (2) (2024)
Nicola Farrington, Vineet Dubey, Adam Johnson, Iona Horner, Adam Stevenson, Jennifer Unsworth, Ana Jimenez-Valverde, Julie Schwartz, Shampa Das, William W Hope, Christopher A Darlow
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa . mBio (2024)
Alessandro Gerada, Nicholas Harper, Alex Howard, Nada Reza, William W Hope
Determination of minimum inhibitory concentrations using machine-learning-assisted agar dilution. Microbiology spectrum 12 (5) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Nada Reza, Alessandro Gerada, Katharine E Stott, Alex Howard, Michael Sharland, William W Hope
Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing. Clinical microbiology reviews (2024)
Nada Reza, Alessandro Gerada, Katharine E Stott, Alex Howard, Michael Sharland, William W Hope
Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing. Clinical microbiology reviews 37 (2) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Nicola Farrington, Vineet Dubey, Adam Johnson, Iona Horner, Adam Stevenson, Jennifer Unsworth, Ana Jimenez-Valverde, Julie Schwartz, Shampa Das, William W Hope, Christopher A Darlow
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa . mBio 15 (2) (2024)
Nicola Farrington, Vineet Dubey, Adam Johnson, Iona Horner, Adam Stevenson, Jennifer Unsworth, Ana Jimenez-Valverde, Julie Schwartz, Shampa Das, William W Hope, Christopher A Darlow
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa . mBio 15 (2) (2024)
Vineet Dubey, Nicola Farrington, Nicholas Harper, Adam Johnson, Iona Horner, Adam Stevenson, Annie Parkes, Lewis Hoare, Shampa Das, William W Hope
Acinetobacter baumannii transformants expressing oxacillinases and metallo-β-lactamases that confer resistance to meropenem: new tools for anti- Acinetobacter drug development and AMR preparedness. Antimicrobial agents and chemotherapy (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Alessandro Gerada, Nicholas Harper, Alex Howard, Nada Reza, William W Hope
Determination of minimum inhibitory concentrations using machine-learning-assisted agar dilution. Microbiology spectrum (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology (2023)
Alex Howard, William W Hope
Assessment of Antifungal Pharmacodynamics. Journal of fungi (Basel, Switzerland) 9 (2) (2023)
Alex Howard, William W Hope
Assessment of Antifungal Pharmacodynamics. Journal of fungi (Basel, Switzerland) 9 (2) (2023)
Alex Howard, William W Hope
Assessment of Antifungal Pharmacodynamics. Journal of fungi (Basel, Switzerland) 9 (2) (2023)
Alex Howard, William W Hope
Assessment of Antifungal Pharmacodynamics. Journal of fungi (Basel, Switzerland) 9 (2) (2023)
Nicola Farrington, Laura McEntee, Adam Johnson, Jennifer Unsworth, Christopher A Darlow, Ana Jimenez-Valverde, Christoph Hornik, Rachel Greenberg, Julie Schwartz, Shampa Das, William W Hope
Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance. Antimicrobial agents and chemotherapy 66 (4) (2022)
Sara E Boyd, Alison Holmes, Richard Peck, David M Livermore, William W Hope
OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline. Antimicrobial agents and chemotherapy 66 (8) (2022)
Charles D Giamberardino, Wiley A Schell, Jennifer L Tenor, Dena L Toffaletti, Julia R Palmucci, Choiselle Marius, Jane-Valeriane K Boua, Quinlyn Soltow, Robert Mansbach, M Arthur Moseley, J Will Thompson, Laura G Dubois, William W Hope, John R Perfect, Karen Joy Shaw
Efficacy of APX2039 in a Rabbit Model of Cryptococcal Meningitis. mBio (2022)
Shampa Das, Martin J Everett, Magdalena Zalacain, William W Hope
Reply to Asempa et al., "The Ongoing Challenge with NDM-Harboring Enterobacteriaceae in Murine Infection Models". Antimicrobial agents and chemotherapy 65 (2) (2021)
Silke Gastine, William W Hope, Georg Hempel, Ruta Petraitiene, Vidmantas Petraitis, Diana Mickiene, John Bacher, Thomas J Walsh, Andreas H Groll
Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy. Antimicrobial agents and chemotherapy 65 (2) (2021)
Katharine E Stott, Thuy Le, Thu Nguyen, Sarah Whalley, Jennifer Unsworth, Vo Trieu Ly, Ruwanthi Kolamunnage-Dona, William W Hope
Population Pharmacokinetics and Pharmacodynamics of Itraconazole for Disseminated Infection Caused by Talaromyces marneffei. Antimicrobial agents and chemotherapy 65 (11) (2021)
Sonia Luque, William W Hope, L Sorli, R Muñoz-Bermudez, N Campillo, J Barceló-Vidal, F Álvarez-Lerma, Juan Pablo Horcajada, J R Masclans-Enviz, M Neely, S Grau
Dosage Individualization of Linezolid: Precision Dosing of Linezolid To Optimize Efficacy and Minimize Toxicity. Antimicrobial agents and chemotherapy 65 (6) (2021)
Laura Lynn Kovanda, Gabriele Sass, Marife Martinez, Karl V Clemons, Hasan Nazik, Therese M Kitt, Nathan P Wiederhold, William W Hope, David A Stevens
Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis. Antimicrobial agents and chemotherapy 65 (6) (2021)
Shampa Das, Richard Fitzgerald, Asad Ullah, Marcin Bula, Andrea M Collins, Elena Mitsi, Jesus Reine, Helen Hill, Jamie Rylance, Daniela M Ferreira, Karen Tripp, Andrea Bertasini, Samantha Franzoni, Mameli Massimiliano, Omar Lahlou, Paola Motta, Philip Barth, Patrick Velicitat, Philipp Knechtle, William W Hope
Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial Pneumonia. Antimicrobial agents and chemotherapy 65 (1) (2020)
Adam Johnson, Laura McEntee, Nicola Farrington, Ruwanthi Kolamunnage-Dona, Samantha Franzoni, Alberto Vezzelli, Mameli Massimiliano, Philipp Knechtle, Adam Belley, Aaron Dane, George Drusano, Shampa Das, William W Hope
Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing Klebsiella pneumoniae. Antimicrobial agents and chemotherapy 64 (6) (2020)
Sara E Boyd, David M Livermore, David C Hooper, William W Hope
Metallo-β-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline. Antimicrobial agents and chemotherapy 64 (10) (2020)
Shampa Das, Adam Johnson, Laura McEntee, Nicola Farrington, Adam Kirby, Jennifer Unsworth, Ana Jimenez-Valverde, Ruwanthi Kolamunnage-Dona, Justine Bousquet, Laethitia Alibaud, Carole Sable, Magdalena Zalacain, Martin J Everett, William W Hope
Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae. Antimicrobial agents and chemotherapy 64 (11) (2020)
Amaya L Bustinduy, Ruwanthi Kolamunnage-Dona, Mark H Mirochnick, Edmund V Capparelli, Veronica Tallo, Luz P Acosta, Remigio M Olveda, Jennifer F Friedman, William W Hope
Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum. Antimicrobial agents and chemotherapy 64 (9) (2020)
James M Byrne, Ursula Waack, Edward A Weinstein, Abhay Joshi, Simone M Shurland, Dmitri Iarikov, Juergen B Bulitta, Binh An Diep, Tina Guina, William W Hope, Matthew B Lawrenz, Alexander J Lepak, Brian M Luna, Lynn Miesel, Andrew J Phipps, Thomas J Walsh, William Weiss, Thushi Amini, John J Farley
FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development. Antimicrobial agents and chemotherapy 65 (1) (2020)
Juergen B Bulitta, William W Hope, Ann E Eakin, Tina Guina, Vincent H Tam, Arnold Louie, George L Drusano, Jennifer L Hoover
Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans. Antimicrobial agents and chemotherapy 63 (5) (2019)
Laura McEntee, Adam Johnson, Nicola Farrington, Jennifer Unsworth, Aaron Dane, Akash Jain, Nicole Cotroneo, Ian Critchley, David Melnick, Thomas Parr, Paul G Ambrose, Shampa Das, William W Hope
Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections. Antimicrobial agents and chemotherapy 63 (8) (2019)
William W Hope, Gary Johnstone, Silvia Cicconi, Timothy Felton, Joanne Goodwin, Sarah Whalley, Anahi Santoyo-Castelazo, Virginia Ramos-Martin, Jodi Lestner, Leah Credidio, Aaron Dane, Daniel F Carr, Munir Pirmohamed, Rahim Salim, Michael Neely
Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study. Antimicrobial agents and chemotherapy 63 (4) (2019)
Laura Lynn Kovanda, Sean M Sullivan, Larry R Smith, Amit V Desai, Pete L Bonate, William W Hope
Population Pharmacokinetic Modeling of VL-2397, a Novel Systemic Antifungal Agent: Analysis of a Single- and Multiple-Ascending-Dose Study in Healthy Subjects. Antimicrobial agents and chemotherapy 63 (6) (2019)
Laura Lynn Kovanda, Charles Giamberardino, Laura McEntee, Dena L Toffaletti, Kelly S Franke, Andrew Bartuska, Gordon Smilnak, George C de Castro, Katelyn Ripple, William W Hope, John R Perfect
Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis. Antimicrobial agents and chemotherapy 63 (9) (2019)
Thuy Le, Vo Trieu Ly, Nguyen Thi Mai Thu, Ashley Nguyen, Nguyen Tat Thanh, Nguyen Van Vinh Chau, Guy Thwaites, John Perfect, Ruwanthi Kolamunnage-Dona, William W Hope
Population Pharmacodynamics of Amphotericin B Deoxycholate for Disseminated Infection Caused by Talaromyces marneffei. Antimicrobial agents and chemotherapy 63 (2) (2019)
William W Hope, Neil R H Stone, Adam Johnson, Laura McEntee, Nicola Farrington, Anahi Santoro-Castelazo, Xuan Liu, Anita Lucaci, Margaret Hughes, Jason D Oliver, Charles Giamberardino, Sayoki Mfinanga, Thomas S Harrison, John R Perfect, Tihana Bicanic
Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance. mBio 10 (6) (2019)
S Luque, William W Hope, N Campillo, R Muñoz-Bermúdez, L Sorli, J Barceló-Vidal, E González-Colominas, F Alvarez-Lerma, J R Masclans, M Montero, Juan Pablo Horcajada, S Grau
Population Pharmacokinetics of Anidulafungin in Critically Ill Patients. Antimicrobial agents and chemotherapy 63 (7) (2019)
Katharine E Stott, Justin Beardsley, Ruwanthi Kolamunnage-Dona, Anahi Santoyo Castelazo, Freddie Mukasa Kibengo, Nguyen Thi Hoang Mai, Nguyễn Lê Nhu' Tùng, Ngo Thi Kim Cuc, Jeremy Day, William W Hope
Correction for Stott et al., "Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis". Antimicrobial agents and chemotherapy 62 (12) (2018)
David R Andes, Mahmoud A Ghannoum, Pranab K Mukherjee, Laura Lynn Kovanda, Qiaoyang Lu, Mark E Jones, Anne Santerre Henriksen, Christopher Lademacher, William W Hope
Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials. Antimicrobial agents and chemotherapy 63 (1) (2018)
Gemma L Nixon, Laura McEntee, Adam Johnson, Nicola Farrington, Sarah Whalley, Joanne Livermore, Cristien Natal, Gina Washbourn, Jaclyn Bibby, Neil Berry, Jodi Lestner, Megan Truong, Andrew Owen, David Lalloo, Ian Charles, William W Hope
Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease. Antimicrobial agents and chemotherapy 62 (4) (2018)
Katharine E Stott, Justin Beardsley, Ruwanthi Kolamunnage-Dona, Anahi Santoyo Castelazo, Freddie Mukasa Kibengo, Nguyen Thi Hoang Mai, Nguyễn Lê Nhu’ Tùng, Ngo Thi Kim Cuc, Jeremy Day, William W Hope
Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis. Antimicrobial agents and chemotherapy 62 (9) (2018)
Katharine E Stott, Justin Beardsley, Sarah Whalley, Freddie Mukasa Kibengo, Nguyen Thi Hoang Mai, Nguyễn Lê Nhu' Tùng, Ngo Thi Kim Cuc, Ruwanthi Kolamunnage-Dona, William W Hope, Jeremy Day
Correction for Stott et al., "Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis". Antimicrobial agents and chemotherapy 62 (12) (2018)
Helen Box, Clara Negri, Joanne Livermore, Sarah Whalley, Adam Johnson, Laura McEntee, Ana-Alastruey Izquierdo, Jacques F Meis, Christopher Thornton, William W Hope
Pharmacodynamics of Voriconazole for Invasive Pulmonary Scedosporiosis. Antimicrobial agents and chemotherapy 62 (5) (2018)
Amit V Desai, Laura Lynn Kovanda, William W Hope, David Andes, Johan W Mouton, Donna L Kowalski, Robert W Townsend, Salim Mujais, Peter L Bonate
Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi. Antimicrobial agents and chemotherapy 61 (12) (2017)
Anne-Hortense Schmitt-Hoffmann, Kota Kato, Robert Townsend, Michael J Potchoiba, William W Hope, David Andes, Jochen Spickermann, Marlowe J Schneidkraut
Tissue Distribution and Elimination of Isavuconazole following Single and Repeat Oral-Dose Administration of Isavuconazonium Sulfate to Rats. Antimicrobial agents and chemotherapy 61 (12) (2017)

William W Hope.css-eqlu8i{font-size:small;padding-left:4px;} (William Hope, W Hope)

Publication Activity (10 Years)

Top Topics

Top Venues

William W Hope (William Hope, W Hope)